EGFR and dermatological toxicity: Contrarily, by using the WoMo score we demonstrated that more patients treated with erythromycin developed moderate or severe skin toxicity at earlier time points indicating that local erythromycin should not be used as a substitute of oral tetracyclines as prophylaxis against EGFR mediated skin toxicity.